These results provide a guide to inform discussions about diabetic retinopathy risk for your patients.
The results are estimated using data from a group of selected adults with Type 2 diabetes enrolled in Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) clinical trial.Caution should be exercised when interpreting these results as your patients may differ from the FIELD study participants.